These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 38664392

  • 1. TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/STAT3 pathway to induce VEGF expression.
    Wang Z, Zhao P, Tian K, Qiao Z, Dong H, Li J, Guan Z, Su H, Song Y, Ma X.
    Cell Death Dis; 2024 Apr 25; 15(4):295. PubMed ID: 38664392
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.
    Liu X, Gao X, Zhang W, Zhu T, Bi W, Zhang Y.
    IUBMB Life; 2018 Jan 25; 70(1):81-91. PubMed ID: 29281186
    [Abstract] [Full Text] [Related]

  • 3. Knockdown of miR-1293 attenuates lung adenocarcinoma angiogenesis via Spry4 upregulation-mediated ERK1/2 signaling inhibition.
    Lou Y, Xu B, Huang K, Li X, Jin H, Ding L, Ning S, Chen X.
    Biochem Pharmacol; 2024 Aug 25; 226():116414. PubMed ID: 38972427
    [Abstract] [Full Text] [Related]

  • 4. Membrane progesterone receptor α (mPRα) enhances hypoxia-induced vascular endothelial growth factor secretion and angiogenesis in lung adenocarcinoma through STAT3 signaling.
    Xia Z, Xiao J, Dai Z, Chen Q.
    J Transl Med; 2022 Feb 05; 20(1):72. PubMed ID: 35123491
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
    Sun D, Zhu Y, Zhao H, Bian T, Li T, Liu K, Feng L, Li H, Hou H.
    Cell Oncol (Dordr); 2021 Oct 05; 44(5):1019-1034. PubMed ID: 34109546
    [Abstract] [Full Text] [Related]

  • 9. DUS4L suppresses invasion and metastasis in LUAD via modulation of PI3K/AKT and ERK/MAPK signaling through GRB2.
    Li Z, Zhao PL, Gao X, Li X, Meng YQ, Li ZQ, Zhai KR, Wei SL, Feng HM, Huang HR, Li B.
    Int Immunopharmacol; 2024 Dec 05; 142(Pt A):113043. PubMed ID: 39216120
    [Abstract] [Full Text] [Related]

  • 10. PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.
    Li Y, Huang H, Chen X, Yu N, Ye X, Chen L, Huang Z.
    Tissue Cell; 2022 Dec 05; 79():101918. PubMed ID: 36148733
    [Abstract] [Full Text] [Related]

  • 11. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
    Yang S, Yang C, Yu F, Ding W, Hu Y, Cheng F, Zhang F, Guan B, Wang X, Lu L, Rao J.
    Cell Death Dis; 2018 Oct 30; 9(11):1105. PubMed ID: 30377291
    [Abstract] [Full Text] [Related]

  • 12. Knockdown of deoxythymidylate kinase suppresses progression and epithelial-mesenchymal-transition of lung adenocarcinoma via STAT3 signaling.
    Yu F, Chen Y, Qiu R, Lin N, Yin Y, Zhuo Y, Lin J, Lai F.
    Physiol Genomics; 2023 May 01; 55(5):213-221. PubMed ID: 36939206
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
    Wan S, Liu Z, Chen Y, Mai Z, Jiang M, Di Q, Sun B.
    Bioengineered; 2021 Dec 01; 12(2):11959-11977. PubMed ID: 34818974
    [Abstract] [Full Text] [Related]

  • 14. The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration.
    Wu X, Wu Z, Xie Z, Huang H, Wang Y, Lv K, Yang H, Liu X.
    Int Immunopharmacol; 2024 Sep 10; 138():112553. PubMed ID: 38943975
    [Abstract] [Full Text] [Related]

  • 15. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K, Luo J, Shao C, Ren Z, Sun S, Zhu Y, Zhou H, Jiang Z, Li X, Gu W, Xu Y, Qiang Y, Ren B, Xu L, Wu H, Shen Y.
    Med Sci Monit; 2020 Feb 28; 26():e920351. PubMed ID: 32108133
    [Abstract] [Full Text] [Related]

  • 16. CHAC1 blockade suppresses progression of lung adenocarcinoma by interfering with glucose metabolism via hijacking PKM2 nuclear translocation.
    Pan J, Wu S, Pan Q, Zhang Y, He L, Yao Q, Chen J, Li J, Xu Y.
    Cell Death Dis; 2024 Oct 05; 15(10):728. PubMed ID: 39368995
    [Abstract] [Full Text] [Related]

  • 17. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C, Dong X, Lu H, Tong F, Chen L, Zhang R, Dong J, Hu Y, Wu G, Dong X.
    J Exp Clin Cancer Res; 2019 Feb 21; 38(1):95. PubMed ID: 30791942
    [Abstract] [Full Text] [Related]

  • 18. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
    Feng Y, Zhou MY, Sun F, Kong Z, Wang J, Sun ZQ, Hu LJ, Wang JL, Hua Q, Yu JP.
    Zhonghua Zhong Liu Za Zhi; 2019 Apr 23; 41(4):263-275. PubMed ID: 31014051
    [Abstract] [Full Text] [Related]

  • 19. Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway.
    Liu M, Wu S, Wu H, Zhou Y, Zhang X, Zhu D, Jiang J.
    J Transl Med; 2024 May 27; 22(1):510. PubMed ID: 38802900
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value and molecular mechanisms of OAS1 in lung adenocarcinoma.
    Wang L, Gao L, Ding F, Gao K, Liu Q, Yin X.
    BMC Pulm Med; 2024 Sep 27; 24(1):473. PubMed ID: 39334033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.